No items in cart
The Zoe Report
Regenerative Aesthetics Are On The Rise
Experts unpack these controversial skin treatments.
by TATIANA BONCOMPAGNI
April 19, 2024
One of the market leaders is Elevai Labs, which is sold primarily through doctors offices and went public on the Nasdaq recently under the ticker symbol ELAB. The company’s founder Jordan Plews was doing post doctoral research at Stanford University when he became interested in using regenerative medicine to revolutionize the science of skin care. Elevai currently has two products, a post-procedure professional treatment and an at-home serum that combines exosomes with ceramides, vitamin C, glutathione, and peptides to address skin concerns such as redness, pigmentation, and fine lines. The proprietary blend is patent-pending.
To read the full article, click here.